33 research outputs found

    A prospective cohort study on consumption of alcoholic beverages in relation to prostate cancer incidence (The Netherlands).

    Get PDF
    Department of Epidemiology, Maastricht University, The Netherlands. [email protected] OBJECTIVES: To examine alcohol consumption in relation to prostate cancer incidence in the Netherlands Cohort Study. METHODS: At baseline in 1986, 58,279 men aged 55-69 years completed a self-administered questionnaire on diet, consumption of alcoholic beverages and other risk factors for cancer. For data processing and analyses the case-cohort approach was used. After 6.3 years of follow-up, 680 incident primary prostate cancer cases were available for analysis. RESULTS: In multivariate analyses adjusted for age, socioeconomic status and family history of prostate cancer, no association between total alcohol consumption, alcohol intake from beer and liquor and prostate cancer risk was found. Increased associations were found for alcohol from white wine and fortified wines compared to nondrinkers, but not for red wine. The RRs (95% CI) in the intake category of > or = 15 g/day were 3.3 (1.2-9.2) and 2.3 (1.2-4.7), respectively, after additional adjustment for total alcohol intake. There was, however, no significant trend in risk. Alcohol intake was more strongly related with localized than with advanced prostate tumors. CONCLUSION: Our results do not support an important role for alcohol in prostate cancer etiology. Nevertheless, for specific types of alcoholic beverages, particularly wines, a positive association was suggested which needs examination in further studies

    A case-cohort study on prostate cancer risk in relation to family history of prostate cancer.

    Get PDF
    We investigated the risk of prostate cancer in relation to a family history of prostate cancer in 58,279 men ages 55-69 years. We found 704 incident cases after 6.3 years of follow-up. Rate ratios and 95% confidence intervals for having an affected vs nonaffected father and brother were, respectively 1.44 (0.80-2.58) and 5.57 (1.61-19.26). We found no evidence for an increasing risk with an increasing percentage of affected family members. The associations we observed were stronger for cases diagnosed before age 70 compared with cases diagnosed after age 70 and for advanced compared with localized tumors

    Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study

    Get PDF
    In the Netherlands Cohort Study, the authors investigated whether anthropometry is associated with prostate cancer risk. At baseline in 1986, 58,279 men aged 55-69 years completed a self- administered questionnaire on diet, anthropometry, and other risk factors for cancer. After 6.3 years of follow-up, 681 cases were available with complete data on height and weight at baseline, and for 523 cases, there were data for weight at age 20 years. In both age-adjusted and multivariate case-cohort analyses (adjusted for age, family history of prostate cancer, and socioeconomic status), height, body mass index (BMI; kg/m2), and lean body mass (kg) at baseline were not associated with prostate cancer risk. The rate ratios of prostate cancer for men with a BMI at age 20 of less than 19, 19-20.9, 21-22.9, 23-24.9, and 25 or greater were 1.00 (reference), 1.06, 1.09, 1.39, and 1.33, respectively (p for trend = 0.02). For gain in BMI from age 20 years to age of the cohort at baseline, an inverse trend in risk was found (p for trend = 0.01), which did not persist after additional adjustment for BMI at age 20 (p for trend = 0.07). In subgroup analyses, no clear associations between anthropometry and advanced prostate cancer were found. Our findings suggest that body composition in young adulthood may already exert an effect on later risk of prostate cancer

    Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Get PDF
    Interindividual clinical variability in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is vast. We report that at least 101 of 987 patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia had neutralizing immunoglobulin G (IgG) autoantibodies (auto-Abs) against interferon-w (IFN-w) (13 patients), against the 13 types of IFN-a (36), or against both (52) at the onset of critical disease; a few also had auto-Abs against the other three type I IFNs. The auto-Abs neutralize the ability of the corresponding type I IFNs to block SARS-CoV-2 infection in vitro. These auto-Abs were not found in 663 individuals with asymptomatic or mild SARS-CoV-2 infection and were present in only 4 of 1227 healthy individuals. Patients with auto-Abs were aged 25 to 87 years and 95 of the 101 were men. A B cell autoimmune phenocopy of inborn errors of type I IFN immunity accounts for life-threatening COVID-19 pneumonia in at least 2.6% of women and 12.5% of men

    Diet and other risk factors for prostate cancer

    Get PDF

    Diet, anthropometric measures and prostate cancer risk: A review of prospective cohort and intervention studies

    Get PDF
    We reviewed 37 prospective cohort and four intervention studies on potential dietary risk factors for prostate cancer, published between 1966 and September 2003. Some studies were limited by small size, crude measurement of dietary exposure and limited control for confounders. Intervention and prospective cohort studies support a protective role against prostate cancer for selenium, and possibly for vitamin E, pulses and tomatoes/lycopene. Overall consumption of meat, eggs, vegetables, fruit, coffee, tea, carotenoids and vitamins A, C and D was not consistently related to prostate cancer risk. Intervention studies also indicate that supplementation with β-carotene does not lower prostate cancer risk, except possibly in men with low β-carotene status at baseline. For specific types of meat, alcoholic drinks, dairy products, fat and anthropometric measures, most cohort studies suggest either an increased risk or no relation with prostate cancer. For calcium, two cohort studies suggest an increased risk at very high calcium intakes (>2000 mg/day). In conclusion, prospective studies are consistent with a protective role for selenium, and possibly vitamin E, pulses and tomatoes/lycopene, in the aetiology of prostate cancer. Studies are inconclusive on the role of meat, dairy products, fat, vegetables, fruits, alcohol and anthropometric measures, whereas a very high calcium intake appears to be positively associated with prostate cancer risk

    Vegetable and fruit consumption and prostate cancer risk: A cohort study in the Netherlands

    Get PDF
    The association between 21 vegetables and eight fruits and prostate cancer risk was assessed in the Netherlands Cohort Study among 58,279 men of ages 55-69 years at baseline in 1986. After 6.3 years of follow-up, 610 cases with complete vegetable data and 642 cases with complete fruit data were available for analysis. In multivariate case-cohort analyses, the following rate ratios (RRs) and 95% confidence intervals (CIs) for vegetable consumption were found (comparing highest versus lowest quintile): total vegetables (RR, 0.80; CI, 0.57-1.12); prepared vegetables (RR, 0.85; CI, 0.61-1.19); and raw vegetables (RR, 0.96; CI, 0.69-1.34). For vegetables categorized in botanical groups, no associations were found except for consumption of pulses (RR, 0.71; CI, 0.51-0.98; P for trend, 0.01). The RRs for total fruit and citrus fruit were 1.31 (CI, 0.96-1.79) and 1.27 (CI, 0.93-1.73), respectively; the corresponding Ps for trend were 0.02 and 0.01, respectively. In a continuous model, no association for total fruit was observed. Individual vegetables and fruits were evaluated as continuous variables (g/day). Nonsignificant inverse associations (RRs per increment of 25 g/day) were found for consumption of kale (RR, 0.74), raw endive (RR, 0.72), mandarins (RR, 0.75), and raisins or other dried fruit (RR, 0.49). Observed positive associations were significant for consumption of leek (RR, 1.38) and oranges (RR, 1.07) and nonsignificant for sweet peppers (RR, 1.60) and mushrooms (RR, 1.49). Results in subgroups of cases were more or less consistent with the overall results. From our study, we cannot conclude that vegetable consumption is important in prostate cancer etiology, but for certain vegetables or fruits, an association cannot be excluded

    A prospective cohort study on intake of retinol, vitamins C and E and carotenoids and prostate cancer risk (Netherlands)

    No full text
    Objectives: The roles of retinol, vitamins C and E, and carotenoids as risk factors for prostate carcinoma are still questionable. We evaluated these in the Netherlands Cohort Study. Methods: The cohort study consisted of 58,279 men ages 55-69 years at baseline in 1986. After 6.3 years of follow-up, 642 incident prostate carcinoma cases were available for analysis. Intakes of retinol, vitamins C and E, and several carotenoids were measured by means of a 150-item semi-quantitative food-frequency questionnaire. Results: In multivariate analyses a positive association with prostate cancer risk was observed for intake of β-cryptoxanthin. Rate ratios (RRs) in increasing quintiles were 1.00 (ref), 0.94, 1.01, 1.16, 1.41; p-trend <0.01. For intake of retinol, vitamins C and E and other carotenoids (α-carotene, β-carotene, lycopene, and lutein/zeaxanthin) no effect on overall prostate cancer risk was found. RRs for vitamin supplement use were decreased, but not significantly. Among nondrinkers, nonsignificant inverse associations were observed for intake of retinol, α-carotene, and β-carotene (RRs, highest vs lowest quintile, were 0.23, 0.60, and 0.76, respectively). Among drinkers, β-cryptoxanthin was positively associated (RR highest vs lowest quintile = 1.40). Conclusions: These data show a positive association between β-cryptoxanthin and prostate cancer risk. Our study also shows inverse associations for retinol, α-carotene, and β-carotene among nondrinkers; this suggests an interaction between vitamins and alcohol consumption, which needs confirmation. Lycopene was not associated with prostate cancer. Chemicals/CAS: Antioxidants; Ascorbic Acid, 50-81-7; beta Carotene, 7235-40-7; Carotenoids, 36-88-4; cryptoxanthin, 472-70-8; Vitamin A, 11103-57-4; Vitamin E, 1406-18-4; Xanthophyll

    Association of energy and fat intake with prostate carcinoma risk : results from the Netherlands Cohort Study

    Get PDF
    BACKGROUND. The roles of energy and fat intake as risk factors for prostate carcinoma are still questionable. Therefore, these factors were evaluated in the Netherlands Cohort Study described in this article
    corecore